Cancers | Free Full-Text | Agonistic CD40 Antibodies in Cancer Treatment
Le CD154 plaquettaire : une nouvelle interface da… – M/S : médecine sciences – Érudit
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders - The Lancet Rheumatology
With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention - Cusabio
The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets | eLife
Zooming in on dendritic cells for CD40 agonists | Nature Cancer
CD40 Bioassay - Creative Biolabs
CD40-CD40L interactions at DC-T cell and T cell-T cell interface.... | Download Scientific Diagram
PDF] CD40/CD40 LIGAND INTERACTIONS IN IMMUNE RESPONSES AND PULMONARY IMMUNITY | Semantic Scholar
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders - The Lancet Rheumatology
Anti-CD40L monoclonal IgG2b antibody | InvivoGen
Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation
9 Relations between the CD28 and CD40 Ligand Pathways : Resting... | Download Scientific Diagram
CD40 — Wikipédia
model of the potential effects of agonist anti-CD40 on the T-cell... | Download Scientific Diagram
Cells | Free Full-Text | Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
CD40: Targeting Co-Stimulatory Pathways for Cancer Immunotherapy
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response - ScienceDirect
CD40 and CD40L Immune Checkpoints for Immuno-oncology Research from Adipogen Life Sciences
Le rôle biologique de l'interaction du CD40L avec l'intégrine α5β1 des lymphocytes T